MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$395,991
Net Income
-$1,883,290
Net Profit Margin
-475.59%
Unit: Dollar
Revenue Breakdown
Gross sales
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
395,991
391,764
472,982
425,864
Cost of sales
160,455
154,739
205,166
171,401
Gross profit
235,536
237,025
267,816
254,463
Selling and marketing
191,438
270,637
438,456
358,535
Research and development
73,351
55,488
135,377
227,993
General and administrative
681,559
1,224,354
1,935,313*
1,122,684
Depreciation and amortization of intangible assets
13,338
15,038
29,871*
16,268
Total operating expenses
959,686
1,565,517
2,539,017
1,725,480
Loss from operations
-724,150
-1,328,492
-2,271,201
-1,471,017
Other income
89
860
255,723*
7,299
Interest expense
-2,153
3,450
3,037*
5,059
Change in fair value of earnout liabilities
-55,996
-96,053
108,728*
-86,104
Inventory write-down
38,917
196,684
-80,283*
47,082
Amortization of debt discount
-
-
0*
0
Loss on forward purchase agreement
-
-
0*
0
Loss on lease termination
-
-
0*
0
Loss on litigation settlement
-1,174,155
-
-
-
Total other income (expense)
-1,159,140
-103,221
224,241
41,262
Loss from operations before income taxes
-1,883,290
-1,431,713
-2,046,960
-1,429,755
Income tax expense
0
0
36,262
0
Loss from continuing operations
-
-
-2,083,222
-1,429,755
Loss from discontinued operations, net of tax
-
-
0*
0
Gain on sale of discontinued operations
-
-
0*
0
Net loss
-1,883,290
-1,431,713
-2,083,222
-1,429,755
Basic EPS
-0.76
-0.75
-1.457
-0.83
Diluted EPS
-
-0.75
-1.457
-0.83
Basic Average Shares
2,475,321
1,899,910
1,429,557*
1,723,434
Diluted Average Shares
-
1,899,910
1,429,557*
1,723,434
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,883,290
(0.17%↑ Y/Y)
Gross sales
$444,967
(-16.98%↓ Y/Y)
Loss from operations
before income taxes
-$1,883,290
(0.17%↑ Y/Y)
Net sales
$395,991
(-21.37%↓ Y/Y)
Discounts and allowances
-$48,976
(-51.32%↓ Y/Y)
Total other income
(expense)
-$1,159,140
(-4064.48%↓ Y/Y)
Loss from operations
-$724,150
(61.04%↑ Y/Y)
Change in fair value of
earnout liabilities
-$55,996
(-288.98%↓ Y/Y)
Gross profit
$235,536
(-22.18%↓ Y/Y)
Other income
$89
(-97.96%↓ Y/Y)
Cost of sales
$160,455
(-20.15%↓ Y/Y)
Loss on litigation
settlement
-$1,174,155
Total operating
expenses
$959,686
(-55.60%↓ Y/Y)
Inventory write-down
$38,917
Interest expense
-$2,153
(-184.07%↓ Y/Y)
General and
administrative
$681,559
(-56.45%↓ Y/Y)
Selling and marketing
$191,438
(-44.59%↓ Y/Y)
Research and development
$73,351
(-67.91%↓ Y/Y)
Depreciation and
amortization of intangible...
$13,338
(-39.88%↓ Y/Y)
Buy us a coffee
Longevity Health Holdings, Inc. (XAGE)
Longevity Health Holdings, Inc. (XAGE)